3 active not recruiting. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow TSHA-102: new trials by email Literature Review of TSHA-102 trials Research Report on TSHA-102
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome TSHA-102 - Rett Syndrome | Phase 3 | Active not recruiting | Taysha Gene Therapies, Inc. | 4 | 2026-05-08 | 2026-08-19 |
| Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study) TSHA-102 - Rett Syndrome | Phase 1 / Phase 2 | Active not recruiting | Taysha Gene Therapies, Inc. | 6 | 2023-12-12 | 2025-10-15 |
| A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study) TSHA-102 - Rett Syndrome | Phase 3 | Active not recruiting | Taysha Gene Therapies, Inc. | 17 | 2023-03-06 | 2026-07-07 |
Neurodevelopmental Disorders (3) · Rett Syndrome (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, X-Linked (2) · Intellectual Disability (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathologic Processes (2) · X-Linked Intellectual Disability (2)
Taysha Gene Therapies, Inc. (3)
United States (3) · Canada (2) · United Kingdom (1)